NCT03792841 2025-10-16
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
Amgen
Phase 1 Terminated
Clinical Trials
7 trialsNCT00031551 2017-12-06
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02109289 2017-02-07
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
Innovaderm Research Inc.
Phase 4 Terminated
NCT01730495 2015-12-02
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Haukeland University Hospital
Phase 2 Terminated
NCT00447265 2013-02-12
Etanercept for the Treatment of Lupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Terminated
NCT00509600 2012-08-07
Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00127387 2012-06-26
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Phase 2/3 Terminated